Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values - Wikidata - wikimedia - TriplyDB

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

http://www.wikidata.org/entity/Q35088188

about

Rational modulation of the innate immune system for neuroprotection in ischemic stroke Mechanisms and potential therapeutic applications of microglial activation after brain injury Immune mechanisms in cerebral ischemic tolerance Transcriptional profiling in rat hair follicles following simulated Blast insult: a new diagnostic tool for traumatic brain injury A possible role of microglia-derived nitric oxide by lipopolysaccharide in activation of astroglial pentose-phosphate pathway via the Keap1/Nrf2 system Functional polymorphisms in toll-like receptor 4 are associated with worse outcome in acute ischemic stroke patients.Toll-like receptor 4 in glial inflammatory responses to air pollution in vitro and in vivo.Luteolin reduces inflammation in Staphylococcus aureus-induced mastitis by inhibiting NF-kB activation and MMPs expression.An atypical role for the myeloid receptor Mincle in central nervous system injury Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents Targeting microglial activation in stroke therapy: pharmacological tools and gender effects.Toll-like receptors and ischemic brain injury.Activation of immune responses to brain antigens after stroke.Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury.LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment.Ischemic transient neurological events identified by immune response to cerebral ischemia.The neurovascular unit and combination treatment strategies for stroke TLR4 rs1927911, but not TLR2 rs5743708, is associated with atherosclerotic cerebral infarction in the Southern Han population: a case-control study.Neuroprotective Effect of Xueshuantong for Injection (Lyophilized) in Transient and Permanent Rat Cerebral Ischemia Model.Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia.Blood microRNAs in low or no risk ischemic stroke patients.Piperine Plays an Anti-Inflammatory Role in Staphylococcus aureus Endometritis by Inhibiting Activation of NF-κB and MAPK Pathways in Mice Activation of Toll-Like Receptors 2 by High-Mobility Group Box 1 in Monocytes from Patients with Ischemic Stroke Neuroprotective Effect of Paeonol Mediates Anti-Inflammation via Suppressing Toll-Like Receptor 2 and Toll-Like Receptor 4 Signaling Pathways in Cerebral Ischemia-Reperfusion Injured Rats.Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism.TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion.Hsp60 chaperonopathies and chaperonotherapy: targets and agents.Endogenous recovery after brain damage: molecular mechanisms that balance neuronal life/death fate.Vectorized nanodelivery systems for ischemic stroke: a concept and a need.Potential medications or compounds acting on toll-like receptors in cerebral ischemia.RIG-I contributes to the innate immune response after cerebral ischemia.Exercise Therapy Downregulates the Overexpression of TLR4, TLR2, MyD88 and NF-κB after Cerebral Ischemia in Rats Heat shock proteins: conditional mediators of inflammation in tumor immunity.Innate immune regulation by toll-like receptors in the brain.Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition.Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke.Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke.Role of pattern recognition receptors of the neurovascular unit in inflamm-aging.

P2860

Q26851831-7C4BE6F3-9E87-4F89-802C-A0BF1F2CD72F Q26864358-AED250F4-DDB3-4716-B62F-24E94501CC30 Q27022067-80CD84C2-B836-401D-9609-26144C9E5F4E Q27315925-8C7C490C-76EE-4BA8-8D0B-7982612D3AB7 Q28833599-B6F69C11-4D26-4804-9195-E9547FEAD794 Q30577527-723CB68A-8EA4-4CBC-AD74-EBA4C862E14E Q33564656-8BB61154-537D-4602-A6B3-907EAF94A35A Q33709753-53267DD2-D9D1-41CF-B040-14BE86DDD0F9 Q33727617-DBB71544-8DB5-4A22-9B1C-849F9F003031 Q33783563-6FE5FD42-1181-42BE-9042-5E40CDDEEF8E Q33824991-2F45A79D-34F0-437E-9987-8F657266817E Q33972758-ABE471F5-7C9D-45BB-8050-69225AB01A21 Q34069139-2385EAF2-74EB-4D45-AF91-8F88F67E9307 Q34510368-51D0F8D8-F5FE-4DBF-9C5C-6AF34AF84AEB Q35088789-B157CA7D-C0EE-4F82-9BC3-3D61F51B193C Q35555026-7DB6FC8D-E0F3-4F22-BAE1-151137020AFF Q35575846-A80E7DC1-A2E7-4F1D-99F8-E5BB23BFBC6D Q35891452-939EDCEB-ACEB-4724-AAFE-0EB504001CBB Q36124038-3F6C61DE-E16A-474F-9843-6F113E42F972 Q36151500-636E805B-1841-41D9-B07F-E9B67E3D528F Q36349762-0A759791-7F08-4F76-A82A-E7BB39969E9C Q36429323-07007F58-9740-4301-9AF7-D74B38DB51FA Q36590184-FF4FB93A-6F79-4171-9F70-F1F18EA0A443 Q36936731-DEA5BB62-BE1D-4829-8BD1-CD592E0DC82E Q37172711-A855FE71-F1AC-4403-8E93-EC20AD5B7E5C Q37560229-AFE2C0AD-2931-4188-8A34-59382070CEDE Q37618722-AA565257-79F8-4769-B73E-E59E9373FDE2 Q38122360-422629EA-C357-457D-9743-5EFC9B03FF60 Q38167037-D09CE73F-6761-4457-BC5E-90982ED24F7C Q38587925-945716E9-9D58-46F0-B040-46B82B4FBA3D Q38731765-7CE2129B-8D90-48A4-9103-952515B94244 Q39344487-397EDD9F-334B-4E09-BA39-9A44C92960AC Q40529865-7961D083-87CC-4EB5-9124-EC66035DE789 Q41615462-93F305BD-421A-43E8-88A7-D436345E236E Q42144085-405FE75D-C66D-4FA9-A293-3D2D832DB935 Q42410751-5C312AEB-AE1C-45DB-B026-0CDA77F340A3 Q47102486-BBD94745-42B2-4C71-A56A-4D3673954151 Q47118391-621BB336-FD2D-4CA3-8F56-1E0234EBCD48 Q47883886-28CED183-1752-4E67-9CB8-CEEED8FF242F Q47962378-C55DAAF5-83C9-4F42-859C-028EA4F38379

P2860

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

http://www.wikidata.org/entity/Q35088188

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

@ast

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

@en

type

label

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

@ast

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

@en

prefLabel

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

@ast

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

@en

P1433

Q35088188-2E947EFB-2407-47A2-8E18-2D2B6A55F0FD

P1476

Q35088188-FC1B5886-24F2-4BFB-AA77-7CB3E43178C9

P2093

Q35088188-2BA84FD4-661F-48B9-8C2B-36A9F24C9BE1

Q35088188-41504A59-5E75-42CE-A782-E461CBB8550E

Q35088188-58F59F27-6C6B-4FCB-996F-A9FAF7B2FD07

Q35088188-9226FB47-3BF2-4311-82EE-8D372B1C8BE4

Q35088188-EC156A4D-E442-4B23-9E7F-034598AF8259

Q35088188-F6B3291A-E1F9-4AC5-8566-BAC24067E5E3

P2860

Q35088188-06F1A36B-D836-425E-8473-158FB2D07AEA

Q35088188-18ABAF89-EBA4-486E-AB03-D6778FB5D6D5

Q35088188-1D0C4E5B-A5D1-41A4-A243-DE7AD802E281

Q35088188-1DCEC785-825C-4CAD-840B-C7F3D310C40A

Q35088188-287F71A9-F045-42FF-84D9-AEEF40E21F21

Q35088188-482C9342-F966-4A0A-9364-3D536174F437

Q35088188-6B5D901A-C200-47BD-BCB3-DF87377F27D2

Q35088188-7FAA6B5B-2CE6-4139-9FBF-690D2321DE7C

Q35088188-89BD7D2E-7BB8-4BA4-8C55-F5FCE89084B8

Q35088188-8E6EA540-D6B2-4D43-AC9D-D0F4B364AD9C

P304

Q35088188-1520B04C-F503-42D0-BFE6-E2357918CB3E

P31

Q35088188-8C25F8EB-DE72-4FEC-92C4-FFD7F88BA177

P356

Q35088188-17DA2550-19AB-448D-8FEE-7E08522B88E7

P433

Q35088188-933D302D-566F-422A-B272-20E6641A6FE1

P478

Q35088188-D1D324FC-0BDF-47A8-82BB-335F8599A67D

P50

Q35088188-9CCEDF5C-256A-472B-B6DD-144EB3928169

Q35088188-BF3CC376-976B-4DDC-A43C-D3A943BB2502

Q35088188-D20FB4F8-C5F3-400C-B2CB-86CF5E1A0775

P577

Q35088188-23DBE965-B89A-45D8-877D-CEBC98A2B2E2

P5875

Q35088188-3E0F7910-8643-4E86-AA0F-0065D045C9B9

P698

Q35088188-3B03AFDC-384F-46D3-865E-B51FD000958F

P921

Q35088188-988F7261-B849-4B89-B8EF-489CD8EF7F52

P932

Q35088188-9859D331-1BDE-4AFF-BE1C-696756895010

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values

@en

P2093

David Brea

http://www.w3.org/2001/XMLSchema#string

María Pérez-Mato

http://www.w3.org/2001/XMLSchema#string

Miguel Blanco

http://www.w3.org/2001/XMLSchema#string

Octavio Moldes

http://www.w3.org/2001/XMLSchema#string

Rogelio Leira

http://www.w3.org/2001/XMLSchema#string

Susana Arias

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

mRNA is an endogenous ligand for Toll-like receptor 3.

ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes.

Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice.

Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.

Signaling mechanism of extracellular RNA in endothelial cells.

Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.

Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets.

Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists

P304

1424-1431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2010.231

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Pedro Ramos-Cabrer

P577

2011-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49729069

http://www.w3.org/2001/XMLSchema#string

P698

21206505

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3130315

http://www.w3.org/2001/XMLSchema#string